NM

#EndSARS: Ogun panel recommends payment of over N218 million to victims

Ogun Governor, Prince Dapo Abiodun, has assured that he will implement the report of the State’s Judicial Panel of Investigation on Police Brutality and Extra Judicial Killings. The Governor who gave the assurance while receiving the report said its implementation was necessary towards having a peaceful society and engendering of a more robust relationship between the people and security agencies. Governor Abiodun who spoke on Friday appreciated the Panel members for their selfless efforts and contributions towards the successful completion of the task. “I believe that the implementation of this report will end the gory experience often encountered by residents of the State”, the Governor assured. The State’s helmsman added that it is important for all of us as a people and security agenci...

Gunmen abduct graduate, one other in Ondo community

Gunmen suspected to be kidnappers have created tension in Ikaram Akoko, in Akoko North West council area of Ondo State, following the abduction of two residents of the community including a graduate, identified as Gbodi. It was gathered that the two victims were abducted within 24 hours in the community while the abductors of one of the victims demanded N10m to secure the freedom of the victim. Gbodi, the HND graduate, was abducted along Okeagbe Ikaram highway while returning from his farm which is few kilometres from his residence, Ikaram, the other victim was kidnapped very close to where some construction workers were abducted recently along Ikaram/Akunu highway. Speaking on the kidnap of the two men, the traditional ruler of the town, the Akala of Ikaram, Oba Andrew Momodu, who confirm...

Lagos hospital presents medical records of Lekki tollgate victims

Reddington Hospital Lagos, Saturday produced the medical records of some of the patients it treated following the Lekki toll gate ‘shootings’ of last October 20. One of the hospital’s trauma and orthopaedic surgeons, Dr. Babajide Lawson, presented the case files to the Lagos State Judicial Panel on Restitution for Victims of SARS and the Lekki Tollgate Incident. The Nigerian Army has been accused of opening fire with live bullets on peaceful protesters at the Toll Gate demanding an end to police brutality using the hash tag #EndSARS. Some of the protesters have submitted petitions to the panel alleging that men of the Army’s 81 Division shot at and killed several #EndSARS protesters that night, a claim the Army denied. The Army has, however, shunned further appearance at the panel, without...

US election: Republicans hold back Democrats, narrowing path to Senate control

The battle for power in the Senate tightened into Wednesday as Democrats picked up a seat in Colorado, but suffered a setback in Alabama, and Republicans held their own in high-profile races in South Carolina, Iowa, Texas and Kansas, dramatically narrowing the political map. Republicans fought to retain their Senate majority by turning back a surge of Democrats challenging allies of President Donald Trump, and the Democrats’ various paths to seizing control were growing more limited. With several contests still too early to call, and one Georgia race heading to a January runoff, the final verdict is expected to drag on. Democrats gained a seat when ex-Gov. John Hickenlooper ousted GOP Sen. Cory Gardner in Colorado, a must-win to flip the Senate, but couldn’t hold on in Alabama, where forme...

Pfizer, BioNTech dose U.S first participants of trial coronavirus vaccine

Pfizer Inc. and BioNTech SE announced on Wednesday, May 6, 2020, that the first participants have been dosed in the U.S in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week. The Phase 1/2 study is designed to determine the safety, immunogenicity and optimal dose level of four mRNA vaccine candidates evaluated in a single, continuous study. The dose level escalation portion (Stage 1) of the Phase 1/2 trial in the U.S will enrol up to 360 healthy subjects into two age cohorts (18-55 and 65-85 years of age). The first subjects immunized in Stage 1 of the study will be healthy adults 18-55 years of age. Older adults will only be immunized with ...